NovaBay Pharmaceuticals Inc (NBY)
0.0788
0.00 (0.00%)
USD |
NYAM |
Apr 26, 16:00
0.0781
0.00 (0.00%)
After-Hours: 20:00
NovaBay Pharmaceuticals Gross Profit (Quarterly): 1.815M for Dec. 31, 2023
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 1.815M |
September 30, 2023 | 1.838M |
June 30, 2023 | 2.306M |
March 31, 2023 | 1.936M |
December 31, 2022 | 1.755M |
September 30, 2022 | 2.375M |
June 30, 2022 | 1.838M |
March 31, 2022 | 1.814M |
December 31, 2021 | 1.678M |
September 30, 2021 | 1.553M |
June 30, 2021 | 1.519M |
March 31, 2021 | 1.352M |
December 31, 2020 | 1.075M |
September 30, 2020 | 1.634M |
June 30, 2020 | 1.944M |
March 31, 2020 | 1.311M |
December 31, 2019 | 1.111M |
September 30, 2019 | 1.214M |
June 30, 2019 | 1.386M |
March 31, 2019 | 1.15M |
December 31, 2018 | 3.184M |
September 30, 2018 | 2.81M |
June 30, 2018 | 2.315M |
March 31, 2018 | 2.696M |
December 31, 2017 | 5.339M |
Date | Value |
---|---|
September 30, 2017 | 3.57M |
June 30, 2017 | 3.424M |
March 31, 2017 | 3.113M |
December 31, 2016 | 3.269M |
September 30, 2016 | 2.872M |
June 30, 2016 | 2.184M |
March 31, 2016 | 1.108M |
December 31, 2015 | 1.044M |
September 30, 2015 | 0.931M |
June 30, 2015 | 0.755M |
March 31, 2015 | 0.39M |
December 31, 2014 | 0.194M |
September 30, 2014 | 0.11M |
June 30, 2014 | 0.105M |
March 31, 2014 | 0.158M |
December 31, 2013 | 0.43M |
September 30, 2013 | 1.056M |
June 30, 2013 | 0.832M |
March 31, 2013 | 0.998M |
December 31, 2012 | 1.105M |
September 30, 2012 | 3.642M |
June 30, 2012 | 0.871M |
March 31, 2012 | 1.32M |
December 31, 2011 | 1.23M |
September 30, 2011 | 2.772M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
1.075M
Minimum
Dec 2020
2.375M
Maximum
Sep 2022
1.656M
Average
1.678M
Median
Dec 2021
Gross Profit (Quarterly) Benchmarks
Eyenovia Inc | 0.00 |
Palatin Technologies Inc | 1.936M |
iBio Inc | -- |
Theriva Biologics Inc | -- |
Oragenics Inc | -- |